AMN Healthcare CEO Susan Salka to retire by end of 2022; search for successor begins

AMN HEALTHCARE SERVICES INC

Salka, CEO for 17 years and with company for 32, will remain in role until successor is named.
Board has engaged a search firm to evaluate internal and external candidates; Chairman Wheat will lead the committee.
Under Salka, AMN revenue grew from $706M to over $4B and enterprise value from ~$600M to over $5B.
Salka will stand for reelection to the board and assist in transition.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Susan R. Salka

President and Chief Executive Officer

AMN · AMN HEALTHCARE SERVICES INC

Filed: March 10, 2022, 6:59 PM ET

After a successful 32-year career with AMN Healthcare Services, Inc. (the “Company”), including 17 years as Chief Executive Officer, Susan R. Salka notified the Board of Directors of the Company (the “Board”) of her intention to retire by the end of the year ending December 31, 2022.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Susan R. Salka departed as President and Chief Executive Officer at AMN HEALTHCARE SERVICES INC.

Action: retire
Role: President and Chief Executive Officer

Exact text from the filing

After a successful 32-year career with AMN Healthcare Services, Inc. (the “Company”), including 17 years as Chief Executive Officer, Susan R. Salka notified the Board of Directors of the Company (the “Board”) of her intention to retire by the end of the year ending December 31, 2022.

View on SEC.gov

AMN HEALTHCARE SERVICES INC filing history →

Source: SEC EDGAR

accession 0000950142-22-000990

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.